Thermo Fisher Scientific Inc. is a high-quality, stable business, but stock is currently overvalued relative to growth ...

Wall Street analysts forecast that Thermo Fisher Scientific (TMO) will report quarterly earnings of $5.20 per share in its upcoming release, pointing to a year-over-year increase of 1%. It is ...

Thermo Fisher Scientific (TMO) is expected to deliver a year-over-year increase in earnings on higher revenues when it ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Applied Biosystems™ PowerFlex™ ...

Even after a more than 15% pullback in its stock price this year, the company has still achieved a 13.8% compound annual ...

Event context and recent performance snapshot Thermo Fisher Scientific (TMO) has attracted fresh attention after a period of ...

Thermo Fisher Scientific serves the pharmaceutical, biotech, and life sciences industries as a strategic contract development ...

Thermo Fisher Scientific Inc. closed 18.23% short of its 52-week high of $643.99, which the company reached on January 22nd.

The HealthVerity agreement is the latest in a series of data partnerships through which Thermo Fisher has been expanding its ...

Provides an automated, functionally closed approach to help address variability and support more reliable, consistent manufacturing outcomes  WALTHAM, Mass., April 2, 2026 — Thermo Fisher Scientific ...

The Applied Biosystems PowerFlex Thermal Cycler (3 x 32-well configuration shown) is a next-generation PCR system designed to help labs manage increasing workflow complexity with enhanced flexibility, ...